Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. (AUPH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
auph · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Buy
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$16.00
Consensus
$12.60
-20.4% upside
Low
$6.00
Median: $13 · Last Close: $15.84
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$12.60
-20.4% upside
High Target
$16
1.0%
Low Target
$6
-62.1%
Current Price
$15.84
as of today
Based on analyst price targets, the AUPH stock price prediction for the next 12 months ranges from $6 to $16. The consensus AUPH price forecast of $12.60 implies -20.4% upside from the current price of $15.84.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $15.97 | ↑ 0.86% |
1-day model range: $15.9–$16.04. Peak: $16.04 (+0.86%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | +11.2% |
| 2028 | $19 | +18.7% |
| 2029 | $20 | +23.5% |
| 2030 | $20 | +26.4% |
| 2031 | — | +28.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AUPH · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2025-11-07 | Jefferies | Upgrade ↑ | Hold→Buy |
| 2025-11-05 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2025-08-01 | RBC Capital | Maintains | Outperform→Outperform |
| 2024-09-16 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-09-09 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-09-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-02-23 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-02-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Aurinia Pharmaceuticals Inc. (AUPH) stock. Of the recent 53 rating actions, 2 were upgrades and 4 were downgrades. 14 analysts currently cover AUPH.
Analyst Recommendation Trends
AUPH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$326M
↓ 26.6% YoY
Revenue Next Year
$384M
↑ 17.8% YoY
EPS This Year
$0.91
EPS Next Year
$1.11
↑ 22.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast AUPH EPS of $0.91 for the current fiscal year, based on estimates from 4 analysts. The AUPH revenue forecast is $326M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AUPH stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AUPH price target is $12.60 (-20.4% upside), with an analyst consensus of Buy.
The AUPH short-term stock prediction for tomorrow is $15.97 (+0.86%). The AUPH stock price prediction for 2027 estimates an average of $18. The AUPH stock prediction for 2030 projects a range of $19–$21.
Aurinia Pharmaceuticals Inc. trades on NASDAQ under the ticker AUPH. The AUPH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 79% of covering analysts.
Frequently asked questions
AUPH forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month AUPH price target is $12.60, with a high forecast of $16.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies -20.4% potential upside from the current price of $15.84.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.